August 16, 2016
Novocure Converts More Than 500 U.S. Patients to Second Generation Optune within Four Weeks of FDA Approval on July 13
The second generation device is less than half the weight and half the size of the first generation Optune System (Photo: Business Wire) August 16, 2016 07:00 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Before starting treatment with Optune in October 2015,… Read More
learn more
August 8, 2016
Novocure to Present at Upcoming Investor Conferences
August 08, 2016 04:05 PM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that it will present at three upcoming investor conferences in August and September. William Doyle, Novocure’s Executive Chairman, will present at the Wedbush PacGrow 2016 Healthcare Conference… Read More
learn more
